Akero Therapeutics (AKRO) reported 96-week data in its trial of advanced MASH patients, and there seem really significant ...

The results of a phase 2b ENLIVEN trial of FGF21 analogue pegozafermin showed it was able to reduce scarring (fibrosis) in the liver of NASH patients at more than three times the rate of a placebo ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

In experiments, if mice could not produce a gut protein, called Ffar4, the researchers found the gut colonies of B. vulgatus shrank. This, in turn, decreased the release of a hormone called FGF21, ...

Comcast unveils ultra-low lag Internet... iOS 18.3 arrives with Apple... T-Mobile iPhones gain Starlink ...

The study indicated that increasing the population of Bacteroides vulgatus in diabetic mice contributed to the ... leading to decreased release of the hormone FGF21, which is associated with ...